{"gene":"PGK2","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":1987,"finding":"PGK2 (pgk-2) is an intronless autosomal gene that arose from the X-linked, intron-containing PGK1 (pgk-1) gene by RNA-mediated gene duplication (retroposition), making it a recruited retroposon expressed exclusively in sperm cells.","method":"Nucleotide sequence analysis and comparative genomics of human and mouse PGK genes","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct sequence analysis with structural evidence (intronless gene), replicated across human and mouse","pmids":["2823118"],"is_preprint":false},{"year":1989,"finding":"A 323-bp region 5' to the PGK2 coding sequence is sufficient to confer testis-specific and developmentally regulated expression, as shown by reporter gene (CAT and luciferase) transgenic mouse experiments.","method":"Transgenic mouse reporter gene assays (CAT and luciferase constructs with various 5' deletions)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic functional dissection with two orthogonal reporters, replicated across constructs","pmids":["2813402"],"is_preprint":false},{"year":1982,"finding":"PGK2 protein first appears in spermatids at stage 12 of spermatogenesis and is present in spermatozoa, but not in earlier germ cell stages or somatic testicular cells, as determined by immunohistochemistry with monoclonal antibodies.","method":"Immunohistochemical localization using monoclonal antibodies against mouse PGK2","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct protein localization by monoclonal antibody IHC in defined cell stages, single lab","pmids":["6765230"],"is_preprint":false},{"year":1992,"finding":"Tissue-specific transcription of Pgk2 is associated with unique protein-DNA interactions at a 40-bp enhancer region upstream of the core promoter: one or two activities are uniquely present in expressing cells (spermatocytes/spermatids) and a third is associated with the non-expressed state in somatic cells. The core promoter GC box binds ubiquitous transcription factor Sp1 and the CAAT box binds CTF-1 in all tissue types.","method":"Electrophoretic mobility shift assay (band shift) with nuclear extracts from expressing and non-expressing tissues; in vitro transcription assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct DNA-binding assays with nuclear extracts from multiple tissue types, single lab, two orthogonal methods","pmids":["1549104"],"is_preprint":false},{"year":1993,"finding":"A positive cis element between nucleotides -82 and -64 of the Pgk2 promoter stimulates transcription in testis extracts via binding of a testis-specific nuclear factor designated TAP-1. TAP-1 binding requires the sequence 5'-GGAA-3' (an Ets-binding motif), and TAP-1 and the Pgk1 transcription inhibitor TIN-1 compete for overlapping binding sequences.","method":"Cell-free in vitro transcription with nuclear extracts; electrophoretic mobility shift assays with mutant oligonucleotides; competition assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro transcription and DNA-binding assays with defined mutations, single lab","pmids":["8441629"],"is_preprint":false},{"year":1994,"finding":"The Pgk2 silencer responsible for repression in somatic cells maps to an 87-bp region (nucleotides -882 to -796) containing two distinct DNA elements that each individually bind nuclear factors but individually have no effect on promoter activity; only when both elements are aligned in tandem do they inhibit transcription.","method":"Deletion mapping; gel mobility shift assays; CAT reporter assays in mouse erythroleukemia cells","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional dissection by reporter assay combined with DNA-binding assays, single lab","pmids":["8163199"],"is_preprint":false},{"year":1999,"finding":"Multiple cis-regulatory elements in the PGK2 promoter function combinatorially to drive testis-specific transcription: disruption of either the 40-bp E1/E4 enhancer region or the Sp1-binding site in the core promoter individually reduced but did not abolish expression, consistent with an 'enhanceosome'-like mechanism.","method":"Transgenic mice carrying CAT reporter constructs with site-directed mutations in PGK2 promoter elements","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic functional mutagenesis, single lab, multiple mutant constructs","pmids":["10330089"],"is_preprint":false},{"year":2000,"finding":"The region between nucleotides -1404 and -685 upstream of the Pgk2 transcription start site acts as a negative regulatory element (silencer) that represses expression in somatic tissues; deletion of this region causes ectopic activation of the Pgk2 promoter in brain and lung while retaining testicular cell-type specificity.","method":"Transgenic mice with beta-galactosidase reporter driven by various Pgk2 upstream regions; RT-PCR, blot hybridization, and in situ hybridization","journal":"Development, growth & differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic deletion analysis with multiple detection methods, single lab","pmids":["10969738"],"is_preprint":false},{"year":2007,"finding":"In vivo chromatin immunoprecipitation and genomic footprinting during spermatogenesis showed that the testis-specific homeodomain factor PBX4 and its coactivator PREP1, along with CREM and SP3, bind the Pgk2 enhancer specifically in cells actively expressing the gene. PBX4/PREP1 binding is proposed as a rate-limiting step for tissue-specific Pgk2 transcription.","method":"In vivo genomic footprinting and chromatin immunoprecipitation (ChIP) with enriched spermatogenic cell populations","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo ChIP and genomic footprinting with defined cell-stage fractions, two orthogonal methods, single lab","pmids":["17875925"],"is_preprint":false},{"year":2009,"finding":"PGK2 is required for sperm motility and male fertility: targeted disruption of Pgk2 eliminates PGK enzymatic activity in sperm and markedly reduces sperm motility and ATP levels, without blocking spermatogenesis or altering testis histology. The glycolytic bypass enzyme acylphosphatase is active in mouse sperm and may partially compensate for PGK2 loss.","method":"Targeted gene disruption by homologous recombination (Pgk2-/- knockout mice); sperm motility assays; ATP measurements; histology; sperm ultrastructure analysis","journal":"Biology of reproduction","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with multiple orthogonal functional readouts (ATP, motility, fertility), replicated in context of prior GAPDHS knockout comparison","pmids":["19759366"],"is_preprint":false},{"year":2009,"finding":"PGK2 catalyzes the first ATP-generating step of glycolysis in sperm (conversion of 1,3-bisphosphoglycerate to 3-phosphoglycerate with ADP phosphorylation to ATP), replacing the somatic PGK1 isozyme which is repressed by meiotic sex chromosome inactivation and postmeiotic sex chromatin during spermatogenesis.","method":"Enzymatic activity assays in sperm from wild-type vs. Pgk2-/- mice; genetic analysis of sex chromosome inactivation context","journal":"Biology of reproduction","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct enzymatic activity measurement in knockout vs. wild-type sperm, mechanistic context established","pmids":["19759366"],"is_preprint":false},{"year":1996,"finding":"Human PGK2 protein retains known structural and functional motifs conserved with PGK1, but lacks any unique intracellular localization signal; in vivo, PGK2 protein is more stable than PGK1 in spermatogenic cells.","method":"cDNA isolation and amino acid sequence analysis; comparison of PGK1 and PGK2 protein distribution during spermatogenesis by immunological methods","journal":"Developmental genetics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, sequence comparison and basic immunodetection; stability comparison not rigorously quantified in abstract","pmids":["9023984"],"is_preprint":false},{"year":2013,"finding":"Transcriptional activation of Pgk2 follows a defined sequential order during spermatogenesis: DNA demethylation in prospermatogonia → CAAT-box factor binding in spermatogonia → chromatin remodeling (nucleosome displacement and histone modification changes) → enhancer/core promoter factor binding → transcription initiation in primary spermatocytes. Core promoter elements direct DNA demethylation and nucleosome reconfiguration, while both enhancer and core promoter elements direct histone modifications and transcription initiation.","method":"ChIP assays for histone modifications and transcription factors; nucleosome mapping; transgene studies with promoter element disruptions in transgenic mice","journal":"Reproduction (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal chromatin assays combined with transgenic functional element analysis, single lab","pmids":["24000349"],"is_preprint":false},{"year":2020,"finding":"Esculetin binds directly to PGK2 protein (as well as GPD2 and GPI) as measured by microscale thermophoresis, and inhibits cellular glycolysis (reduced lactate production and glucose consumption) in HepG2 cancer cells.","method":"Microscale thermophoresis (MST) binding assays; cellular glycolysis assays (lactate production, glucose consumption); animal tumor models","journal":"Frontiers in pharmacology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single binding method (MST) without mutagenesis or structural validation; cellular effects may reflect multi-target activity; single lab","pmids":["32292350"],"is_preprint":false}],"current_model":"PGK2 is a testis-specific glycolytic enzyme (a retroposon-derived isozyme of PGK1) that catalyzes the first ATP-generating step of glycolysis in sperm; it is transcriptionally activated in primary spermatocytes through a sequential program involving DNA demethylation, chromatin remodeling, and binding of testis-specific factors (PBX4, PREP1, CREM, SP3) to promoter/enhancer elements, replaces the silenced X-linked PGK1 during meiosis, and is essential for sperm ATP production, motility, and male fertility as demonstrated by knockout mice."},"narrative":{"mechanistic_narrative":"PGK2 is a testis-specific glycolytic enzyme that catalyzes the first ATP-generating step of glycolysis in sperm, converting 1,3-bisphosphoglycerate to 3-phosphoglycerate with phosphorylation of ADP to ATP [PMID:19759366]. It is an intronless autosomal gene that arose by RNA-mediated retroposition of the X-linked, intron-containing PGK1, and is expressed exclusively in spermatogenic cells [PMID:2823118], where its protein first appears in spermatids and persists in spermatozoa [PMID:6765230]. PGK2 functionally replaces the somatic PGK1 isozyme during spermatogenesis, when X-linked PGK1 is silenced by meiotic sex chromosome inactivation and postmeiotic sex chromatin [PMID:19759366]. Targeted disruption of Pgk2 eliminates sperm PGK activity and markedly reduces sperm ATP levels and motility, causing impaired male fertility without blocking spermatogenesis or altering testis histology [PMID:19759366]. Testis-restricted expression is achieved through a compact promoter/enhancer in which combinatorial cis-elements act in an enhanceosome-like manner [PMID:10330089]: a sequential activation program proceeds from DNA demethylation through chromatin remodeling to binding of testis-specific factors including PBX4, PREP1, CREM and SP3 at the enhancer in cells actively transcribing the gene [PMID:17875925, PMID:24000349], while upstream silencer elements repress ectopic expression in somatic tissues [PMID:10969738].","teleology":[{"year":1982,"claim":"Establishing when and where PGK2 protein accumulates defined it as a postmeiotic, germ-cell-restricted product rather than a constitutive isozyme.","evidence":"Immunohistochemistry with monoclonal antibodies across defined spermatogenic stages","pmids":["6765230"],"confidence":"Medium","gaps":["Did not establish the enzymatic or functional requirement for the protein","Single lab, antibody-based detection only"]},{"year":1987,"claim":"Determining the genomic origin of PGK2 showed it is a retroposon-derived, intronless duplicate of X-linked PGK1, explaining why an autosomal copy exists at all.","evidence":"Nucleotide sequence and comparative genomic analysis of human and mouse PGK genes","pmids":["2823118"],"confidence":"High","gaps":["Did not address how testis-specific expression is achieved","Did not test functional role in sperm"]},{"year":1989,"claim":"Localizing the information for tissue specificity showed a small 5' region is sufficient to confer testis-specific, developmentally regulated expression, defining the regulatory unit to dissect.","evidence":"Transgenic mouse CAT and luciferase reporter assays with 5' deletions","pmids":["2813402"],"confidence":"High","gaps":["Did not identify the trans-acting factors involved","Did not resolve enhancer vs silencer contributions"]},{"year":1992,"claim":"Identifying tissue-specific protein-DNA interactions distinguished a 40-bp enhancer bound by cell-restricted activities from a core promoter bound by ubiquitous Sp1 and CTF-1, framing specificity as combinatorial.","evidence":"EMSA with nuclear extracts from expressing and non-expressing tissues plus in vitro transcription","pmids":["1549104"],"confidence":"Medium","gaps":["Did not molecularly identify the testis-specific factors","In vitro binding not confirmed in vivo"]},{"year":1993,"claim":"Defining a positive cis element and its Ets-like binding factor (TAP-1) that competes with the PGK1 inhibitor TIN-1 linked PGK2 activation to reciprocal regulation of the two isozymes.","evidence":"Cell-free in vitro transcription, EMSA with mutant oligonucleotides, and competition assays","pmids":["8441629"],"confidence":"Medium","gaps":["TAP-1 identity not molecularly cloned","Reciprocal regulation with PGK1 inferred from in vitro competition only"]},{"year":1994,"claim":"Mapping the somatic silencer to a tandem two-element module explained how PGK2 is actively repressed outside germ cells.","evidence":"Deletion mapping, gel-shift, and CAT reporter assays in erythroleukemia cells","pmids":["8163199"],"confidence":"Medium","gaps":["Silencer-binding factors not identified","Mechanism of tandem-element cooperativity unresolved"]},{"year":2000,"claim":"In vivo deletion of an upstream negative element showed it restricts expression to germ cells, since its loss caused ectopic activation in brain and lung.","evidence":"Transgenic mice with beta-galactosidase reporters and RT-PCR/in situ hybridization","pmids":["10969738"],"confidence":"Medium","gaps":["Factors mediating silencing not identified","Relationship to earlier mapped silencer not fully resolved"]},{"year":1999,"claim":"Showing that single-element mutations reduced but did not abolish expression established an enhanceosome-like combinatorial logic for testis-specific transcription.","evidence":"Transgenic mice with site-directed mutations in PGK2 promoter elements driving CAT","pmids":["10330089"],"confidence":"Medium","gaps":["Individual factor contributions not separated","Did not define the order of factor assembly"]},{"year":2007,"claim":"Identifying PBX4/PREP1, CREM, and SP3 as enhancer-bound factors in expressing cells, with PBX4/PREP1 binding as a rate-limiting step, provided the trans-acting basis for cell-type-specific activation.","evidence":"In vivo genomic footprinting and ChIP on enriched spermatogenic cell fractions","pmids":["17875925"],"confidence":"Medium","gaps":["Causal requirement of each factor not tested by loss-of-function","Single lab"]},{"year":2009,"claim":"Knockout of Pgk2 showed it is the source of sperm PGK activity and is required for sperm ATP production, motility, and fertility, directly establishing PGK2's physiological function as the glycolytic enzyme replacing silenced PGK1.","evidence":"Targeted Pgk2 disruption in mice with enzymatic, ATP, motility, fertility, and histology readouts","pmids":["19759366"],"confidence":"High","gaps":["Extent of acylphosphatase compensation not quantified","Did not resolve subcellular partitioning of glycolytic flux in the flagellum"]},{"year":2013,"claim":"Ordering the activation program (demethylation → CAAT-factor binding → chromatin remodeling → enhancer/promoter factor binding → initiation) integrated the cis/trans findings into a sequential, stage-specific epigenetic cascade.","evidence":"ChIP for histone marks and factors, nucleosome mapping, and transgene element-disruption studies in mice","pmids":["24000349"],"confidence":"Medium","gaps":["Causal hierarchy among steps largely correlative","Enzymes driving demethylation not identified"]},{"year":2020,"claim":"A small-molecule (esculetin) was shown to bind PGK2 directly and inhibit glycolysis, raising PGK2 as a potential pharmacological target.","evidence":"Microscale thermophoresis binding and cellular glycolysis assays in HepG2 cells","pmids":["32292350"],"confidence":"Low","gaps":["Single binding method without mutagenesis or structural validation","Cellular effects may reflect multi-target activity including GPD2 and GPI","PGK2 expression in HepG2 context not established"]},{"year":null,"claim":"How PGK2-driven ATP generation is spatially coupled to flagellar function and the extent to which alternative routes compensate for its loss remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Quantitative contribution of acylphosphatase bypass not defined","No structural model distinguishing PGK2 from PGK1 function established in the corpus","Loss-of-function tests of individual enhancer factors lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[10,9]}],"localization":[],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[10,9]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[9,2]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P07205","full_name":"Phosphoglycerate kinase 2","aliases":["Phosphoglycerate kinase, testis specific"],"length_aa":417,"mass_kda":44.8,"function":"Catalyzes the reversible conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate and plays a role in glycolysis and gluconeogenesis (By similarity). Essential for sperm motility and male fertility (PubMed:26677959). Not required for the completion of spermatogenesis (By similarity)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P07205/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PGK2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"PGK1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PGK2","total_profiled":1310},"omim":[{"mim_id":"311800","title":"PHOSPHOGLYCERATE KINASE 1; PGK1","url":"https://www.omim.org/entry/311800"},{"mim_id":"300144","title":"GLUTAMATE DEHYDROGENASE 2; GLUD2","url":"https://www.omim.org/entry/300144"},{"mim_id":"187430","title":"CYSTEINE-RICH SECRETORY PROTEIN 2; CRISP2","url":"https://www.omim.org/entry/187430"},{"mim_id":"172270","title":"PHOSPHOGLYCERATE KINASE 2; PGK2","url":"https://www.omim.org/entry/172270"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mid piece","reliability":"Approved"},{"location":"Principal piece","reliability":"Approved"},{"location":"End piece","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"testis","ntpm":186.8}],"url":"https://www.proteinatlas.org/search/PGK2"},"hgnc":{"alias_symbol":["PGKPS","PGK-2"],"prev_symbol":[]},"alphafold":{"accession":"P07205","domains":[{"cath_id":"3.40.50.1260","chopping":"8-185","consensus_level":"high","plddt":97.4684,"start":8,"end":185},{"cath_id":"3.40.50.1260","chopping":"199-392","consensus_level":"high","plddt":96.568,"start":199,"end":392}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P07205","model_url":"https://alphafold.ebi.ac.uk/files/AF-P07205-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P07205-F1-predicted_aligned_error_v6.png","plddt_mean":96.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PGK2","jax_strain_url":"https://www.jax.org/strain/search?query=PGK2"},"sequence":{"accession":"P07205","fasta_url":"https://rest.uniprot.org/uniprotkb/P07205.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P07205/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P07205"}},"corpus_meta":[{"pmid":"1690874","id":"PMC_1690874","title":"Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis.","date":"1990","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1690874","citation_count":226,"is_preprint":false},{"pmid":"19759366","id":"PMC_19759366","title":"Phosphoglycerate kinase 2 (PGK2) is essential for sperm function and male fertility in mice.","date":"2009","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/19759366","citation_count":206,"is_preprint":false},{"pmid":"2823118","id":"PMC_2823118","title":"The testis-specific phosphoglycerate kinase gene pgk-2 is a recruited retroposon.","date":"1987","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2823118","citation_count":171,"is_preprint":false},{"pmid":"2813402","id":"PMC_2813402","title":"Transcriptional regulatory regions of testis-specific PGK2 defined in transgenic mice.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2813402","citation_count":131,"is_preprint":false},{"pmid":"2027764","id":"PMC_2027764","title":"Determining transcript number using the polymerase chain reaction: Pgk-2, mP2, and PGK-2 transgene mRNA levels during spermatogenesis.","date":"1991","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/2027764","citation_count":73,"is_preprint":false},{"pmid":"1549104","id":"PMC_1549104","title":"Protein-DNA interactions associated with the onset of testis-specific expression of the mammalian Pgk-2 gene.","date":"1992","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1549104","citation_count":58,"is_preprint":false},{"pmid":"9023984","id":"PMC_9023984","title":"Analysis of the cDNA and encoded protein of the human testis-specific PGK-2 gene.","date":"1996","source":"Developmental genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9023984","citation_count":46,"is_preprint":false},{"pmid":"2156237","id":"PMC_2156237","title":"Molecular evolution of the human Pgk-2 retroposon.","date":"1990","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/2156237","citation_count":43,"is_preprint":false},{"pmid":"32292350","id":"PMC_32292350","title":"Esculetin Inhibits Cancer Cell Glycolysis by Binding Tumor PGK2, GPD2, and GPI.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32292350","citation_count":39,"is_preprint":false},{"pmid":"17875925","id":"PMC_17875925","title":"In vivo analysis of developmentally and evolutionarily dynamic protein-DNA interactions regulating transcription of the Pgk2 gene during mammalian spermatogenesis.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17875925","citation_count":37,"is_preprint":false},{"pmid":"8441629","id":"PMC_8441629","title":"A factor stimulating transcription of the testis-specific Pgk-2 gene recognizes a sequence similar to the binding site for a transcription inhibitor of the somatic-type Pgk-1 gene.","date":"1993","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8441629","citation_count":36,"is_preprint":false},{"pmid":"10330089","id":"PMC_10330089","title":"Multiple elements influence transcriptional regulation from the human testis-specific PGK2 promoter in transgenic mice.","date":"1999","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/10330089","citation_count":33,"is_preprint":false},{"pmid":"624931","id":"PMC_624931","title":"Localization of mouse Pgk-2 gene at the D end of the H-2 complex (1).","date":"1978","source":"The Journal of experimental zoology","url":"https://pubmed.ncbi.nlm.nih.gov/624931","citation_count":31,"is_preprint":false},{"pmid":"6765230","id":"PMC_6765230","title":"Immunohistochemical localization of mouse testis-specific phosphoglycerate kinase (PGK-2) by monoclonal antibodies.","date":"1982","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/6765230","citation_count":19,"is_preprint":false},{"pmid":"15599558","id":"PMC_15599558","title":"Molecular characterization of the porcine testis-specific phosphoglycerate kinase 2 (PGK2) gene and its association with male fertility.","date":"2004","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/15599558","citation_count":17,"is_preprint":false},{"pmid":"908917","id":"PMC_908917","title":"An allelic isozyme of mouse PGK-2 with low activity.","date":"1977","source":"The Journal of experimental zoology","url":"https://pubmed.ncbi.nlm.nih.gov/908917","citation_count":16,"is_preprint":false},{"pmid":"33507524","id":"PMC_33507524","title":"The Germ Cell-Specific Markers ZPBP2 and PGK2 in Testicular Biopsies Can Predict the Presence as well as the Quality of Sperm in Non-obstructive Azoospermia Patients.","date":"2021","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/33507524","citation_count":15,"is_preprint":false},{"pmid":"29407897","id":"PMC_29407897","title":"Species-specific expression of phosphoglycerate kinase 2 (PGK2) in the developing porcine testis.","date":"2018","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/29407897","citation_count":8,"is_preprint":false},{"pmid":"8163199","id":"PMC_8163199","title":"The silencer of mouse Pgk-2 consists of two discrete DNA elements that individually have no effect.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8163199","citation_count":8,"is_preprint":false},{"pmid":"24000349","id":"PMC_24000349","title":"Sequence-specific promoter elements regulate temporal-specific changes in chromatin required for testis-specific activation of the Pgk2 gene.","date":"2013","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24000349","citation_count":6,"is_preprint":false},{"pmid":"7338719","id":"PMC_7338719","title":"Linkage disequilibrium between the T/t complex and Pgk-2 in wild mice.","date":"1981","source":"The Journal of experimental zoology","url":"https://pubmed.ncbi.nlm.nih.gov/7338719","citation_count":5,"is_preprint":false},{"pmid":"10969738","id":"PMC_10969738","title":"Ectopic activation of the transcription promoter for the testis-specific mouse Pgk-2 gene on elimination of a cis-acting upstream DNA region.","date":"2000","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/10969738","citation_count":4,"is_preprint":false},{"pmid":"40114829","id":"PMC_40114829","title":"Seminal plasma PGK2 serves as a predictive biomarker for post-varicocelectomy sperm motility improvement in varicocele subjects.","date":"2025","source":"Translational andrology and urology","url":"https://pubmed.ncbi.nlm.nih.gov/40114829","citation_count":2,"is_preprint":false},{"pmid":"1634238","id":"PMC_1634238","title":"A single nucleotide substitution in the phosphoglycerate kinase (PGK)-1 gene occurred after the separation of PGK-1 and PGK-2.","date":"1992","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1634238","citation_count":1,"is_preprint":false},{"pmid":"16688886","id":"PMC_16688886","title":"Characterization of the PGK2 associated microsatellite S0719 on SSC7 suitable for parentage and QTL diagnosis.","date":"2006","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/16688886","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.12.08.627442","title":"Generation of a Transgenic Mouse Model for Investigating Mitochondria in Sperm","date":"2024-12-09","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.08.627442","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12952,"output_tokens":3280,"usd":0.044028,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10841,"output_tokens":3340,"usd":0.068852,"stage2_stop_reason":"end_turn"},"total_usd":0.11288,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"PGK2 (pgk-2) is an intronless autosomal gene that arose from the X-linked, intron-containing PGK1 (pgk-1) gene by RNA-mediated gene duplication (retroposition), making it a recruited retroposon expressed exclusively in sperm cells.\",\n      \"method\": \"Nucleotide sequence analysis and comparative genomics of human and mouse PGK genes\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct sequence analysis with structural evidence (intronless gene), replicated across human and mouse\",\n      \"pmids\": [\"2823118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"A 323-bp region 5' to the PGK2 coding sequence is sufficient to confer testis-specific and developmentally regulated expression, as shown by reporter gene (CAT and luciferase) transgenic mouse experiments.\",\n      \"method\": \"Transgenic mouse reporter gene assays (CAT and luciferase constructs with various 5' deletions)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic functional dissection with two orthogonal reporters, replicated across constructs\",\n      \"pmids\": [\"2813402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1982,\n      \"finding\": \"PGK2 protein first appears in spermatids at stage 12 of spermatogenesis and is present in spermatozoa, but not in earlier germ cell stages or somatic testicular cells, as determined by immunohistochemistry with monoclonal antibodies.\",\n      \"method\": \"Immunohistochemical localization using monoclonal antibodies against mouse PGK2\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein localization by monoclonal antibody IHC in defined cell stages, single lab\",\n      \"pmids\": [\"6765230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Tissue-specific transcription of Pgk2 is associated with unique protein-DNA interactions at a 40-bp enhancer region upstream of the core promoter: one or two activities are uniquely present in expressing cells (spermatocytes/spermatids) and a third is associated with the non-expressed state in somatic cells. The core promoter GC box binds ubiquitous transcription factor Sp1 and the CAAT box binds CTF-1 in all tissue types.\",\n      \"method\": \"Electrophoretic mobility shift assay (band shift) with nuclear extracts from expressing and non-expressing tissues; in vitro transcription assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct DNA-binding assays with nuclear extracts from multiple tissue types, single lab, two orthogonal methods\",\n      \"pmids\": [\"1549104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"A positive cis element between nucleotides -82 and -64 of the Pgk2 promoter stimulates transcription in testis extracts via binding of a testis-specific nuclear factor designated TAP-1. TAP-1 binding requires the sequence 5'-GGAA-3' (an Ets-binding motif), and TAP-1 and the Pgk1 transcription inhibitor TIN-1 compete for overlapping binding sequences.\",\n      \"method\": \"Cell-free in vitro transcription with nuclear extracts; electrophoretic mobility shift assays with mutant oligonucleotides; competition assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro transcription and DNA-binding assays with defined mutations, single lab\",\n      \"pmids\": [\"8441629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The Pgk2 silencer responsible for repression in somatic cells maps to an 87-bp region (nucleotides -882 to -796) containing two distinct DNA elements that each individually bind nuclear factors but individually have no effect on promoter activity; only when both elements are aligned in tandem do they inhibit transcription.\",\n      \"method\": \"Deletion mapping; gel mobility shift assays; CAT reporter assays in mouse erythroleukemia cells\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional dissection by reporter assay combined with DNA-binding assays, single lab\",\n      \"pmids\": [\"8163199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Multiple cis-regulatory elements in the PGK2 promoter function combinatorially to drive testis-specific transcription: disruption of either the 40-bp E1/E4 enhancer region or the Sp1-binding site in the core promoter individually reduced but did not abolish expression, consistent with an 'enhanceosome'-like mechanism.\",\n      \"method\": \"Transgenic mice carrying CAT reporter constructs with site-directed mutations in PGK2 promoter elements\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic functional mutagenesis, single lab, multiple mutant constructs\",\n      \"pmids\": [\"10330089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The region between nucleotides -1404 and -685 upstream of the Pgk2 transcription start site acts as a negative regulatory element (silencer) that represses expression in somatic tissues; deletion of this region causes ectopic activation of the Pgk2 promoter in brain and lung while retaining testicular cell-type specificity.\",\n      \"method\": \"Transgenic mice with beta-galactosidase reporter driven by various Pgk2 upstream regions; RT-PCR, blot hybridization, and in situ hybridization\",\n      \"journal\": \"Development, growth & differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic deletion analysis with multiple detection methods, single lab\",\n      \"pmids\": [\"10969738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In vivo chromatin immunoprecipitation and genomic footprinting during spermatogenesis showed that the testis-specific homeodomain factor PBX4 and its coactivator PREP1, along with CREM and SP3, bind the Pgk2 enhancer specifically in cells actively expressing the gene. PBX4/PREP1 binding is proposed as a rate-limiting step for tissue-specific Pgk2 transcription.\",\n      \"method\": \"In vivo genomic footprinting and chromatin immunoprecipitation (ChIP) with enriched spermatogenic cell populations\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo ChIP and genomic footprinting with defined cell-stage fractions, two orthogonal methods, single lab\",\n      \"pmids\": [\"17875925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PGK2 is required for sperm motility and male fertility: targeted disruption of Pgk2 eliminates PGK enzymatic activity in sperm and markedly reduces sperm motility and ATP levels, without blocking spermatogenesis or altering testis histology. The glycolytic bypass enzyme acylphosphatase is active in mouse sperm and may partially compensate for PGK2 loss.\",\n      \"method\": \"Targeted gene disruption by homologous recombination (Pgk2-/- knockout mice); sperm motility assays; ATP measurements; histology; sperm ultrastructure analysis\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with multiple orthogonal functional readouts (ATP, motility, fertility), replicated in context of prior GAPDHS knockout comparison\",\n      \"pmids\": [\"19759366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PGK2 catalyzes the first ATP-generating step of glycolysis in sperm (conversion of 1,3-bisphosphoglycerate to 3-phosphoglycerate with ADP phosphorylation to ATP), replacing the somatic PGK1 isozyme which is repressed by meiotic sex chromosome inactivation and postmeiotic sex chromatin during spermatogenesis.\",\n      \"method\": \"Enzymatic activity assays in sperm from wild-type vs. Pgk2-/- mice; genetic analysis of sex chromosome inactivation context\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct enzymatic activity measurement in knockout vs. wild-type sperm, mechanistic context established\",\n      \"pmids\": [\"19759366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Human PGK2 protein retains known structural and functional motifs conserved with PGK1, but lacks any unique intracellular localization signal; in vivo, PGK2 protein is more stable than PGK1 in spermatogenic cells.\",\n      \"method\": \"cDNA isolation and amino acid sequence analysis; comparison of PGK1 and PGK2 protein distribution during spermatogenesis by immunological methods\",\n      \"journal\": \"Developmental genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, sequence comparison and basic immunodetection; stability comparison not rigorously quantified in abstract\",\n      \"pmids\": [\"9023984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Transcriptional activation of Pgk2 follows a defined sequential order during spermatogenesis: DNA demethylation in prospermatogonia → CAAT-box factor binding in spermatogonia → chromatin remodeling (nucleosome displacement and histone modification changes) → enhancer/core promoter factor binding → transcription initiation in primary spermatocytes. Core promoter elements direct DNA demethylation and nucleosome reconfiguration, while both enhancer and core promoter elements direct histone modifications and transcription initiation.\",\n      \"method\": \"ChIP assays for histone modifications and transcription factors; nucleosome mapping; transgene studies with promoter element disruptions in transgenic mice\",\n      \"journal\": \"Reproduction (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal chromatin assays combined with transgenic functional element analysis, single lab\",\n      \"pmids\": [\"24000349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Esculetin binds directly to PGK2 protein (as well as GPD2 and GPI) as measured by microscale thermophoresis, and inhibits cellular glycolysis (reduced lactate production and glucose consumption) in HepG2 cancer cells.\",\n      \"method\": \"Microscale thermophoresis (MST) binding assays; cellular glycolysis assays (lactate production, glucose consumption); animal tumor models\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single binding method (MST) without mutagenesis or structural validation; cellular effects may reflect multi-target activity; single lab\",\n      \"pmids\": [\"32292350\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PGK2 is a testis-specific glycolytic enzyme (a retroposon-derived isozyme of PGK1) that catalyzes the first ATP-generating step of glycolysis in sperm; it is transcriptionally activated in primary spermatocytes through a sequential program involving DNA demethylation, chromatin remodeling, and binding of testis-specific factors (PBX4, PREP1, CREM, SP3) to promoter/enhancer elements, replaces the silenced X-linked PGK1 during meiosis, and is essential for sperm ATP production, motility, and male fertility as demonstrated by knockout mice.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PGK2 is a testis-specific glycolytic enzyme that catalyzes the first ATP-generating step of glycolysis in sperm, converting 1,3-bisphosphoglycerate to 3-phosphoglycerate with phosphorylation of ADP to ATP [#10]. It is an intronless autosomal gene that arose by RNA-mediated retroposition of the X-linked, intron-containing PGK1, and is expressed exclusively in spermatogenic cells [#0], where its protein first appears in spermatids and persists in spermatozoa [#2]. PGK2 functionally replaces the somatic PGK1 isozyme during spermatogenesis, when X-linked PGK1 is silenced by meiotic sex chromosome inactivation and postmeiotic sex chromatin [#10]. Targeted disruption of Pgk2 eliminates sperm PGK activity and markedly reduces sperm ATP levels and motility, causing impaired male fertility without blocking spermatogenesis or altering testis histology [#9]. Testis-restricted expression is achieved through a compact promoter/enhancer in which combinatorial cis-elements act in an enhanceosome-like manner [#6]: a sequential activation program proceeds from DNA demethylation through chromatin remodeling to binding of testis-specific factors including PBX4, PREP1, CREM and SP3 at the enhancer in cells actively transcribing the gene [#8, #12], while upstream silencer elements repress ectopic expression in somatic tissues [#7].\",\n  \"teleology\": [\n    {\n      \"year\": 1982,\n      \"claim\": \"Establishing when and where PGK2 protein accumulates defined it as a postmeiotic, germ-cell-restricted product rather than a constitutive isozyme.\",\n      \"evidence\": \"Immunohistochemistry with monoclonal antibodies across defined spermatogenic stages\",\n      \"pmids\": [\"6765230\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not establish the enzymatic or functional requirement for the protein\", \"Single lab, antibody-based detection only\"]\n    },\n    {\n      \"year\": 1987,\n      \"claim\": \"Determining the genomic origin of PGK2 showed it is a retroposon-derived, intronless duplicate of X-linked PGK1, explaining why an autosomal copy exists at all.\",\n      \"evidence\": \"Nucleotide sequence and comparative genomic analysis of human and mouse PGK genes\",\n      \"pmids\": [\"2823118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address how testis-specific expression is achieved\", \"Did not test functional role in sperm\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Localizing the information for tissue specificity showed a small 5' region is sufficient to confer testis-specific, developmentally regulated expression, defining the regulatory unit to dissect.\",\n      \"evidence\": \"Transgenic mouse CAT and luciferase reporter assays with 5' deletions\",\n      \"pmids\": [\"2813402\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the trans-acting factors involved\", \"Did not resolve enhancer vs silencer contributions\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Identifying tissue-specific protein-DNA interactions distinguished a 40-bp enhancer bound by cell-restricted activities from a core promoter bound by ubiquitous Sp1 and CTF-1, framing specificity as combinatorial.\",\n      \"evidence\": \"EMSA with nuclear extracts from expressing and non-expressing tissues plus in vitro transcription\",\n      \"pmids\": [\"1549104\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not molecularly identify the testis-specific factors\", \"In vitro binding not confirmed in vivo\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Defining a positive cis element and its Ets-like binding factor (TAP-1) that competes with the PGK1 inhibitor TIN-1 linked PGK2 activation to reciprocal regulation of the two isozymes.\",\n      \"evidence\": \"Cell-free in vitro transcription, EMSA with mutant oligonucleotides, and competition assays\",\n      \"pmids\": [\"8441629\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TAP-1 identity not molecularly cloned\", \"Reciprocal regulation with PGK1 inferred from in vitro competition only\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Mapping the somatic silencer to a tandem two-element module explained how PGK2 is actively repressed outside germ cells.\",\n      \"evidence\": \"Deletion mapping, gel-shift, and CAT reporter assays in erythroleukemia cells\",\n      \"pmids\": [\"8163199\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Silencer-binding factors not identified\", \"Mechanism of tandem-element cooperativity unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"In vivo deletion of an upstream negative element showed it restricts expression to germ cells, since its loss caused ectopic activation in brain and lung.\",\n      \"evidence\": \"Transgenic mice with beta-galactosidase reporters and RT-PCR/in situ hybridization\",\n      \"pmids\": [\"10969738\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Factors mediating silencing not identified\", \"Relationship to earlier mapped silencer not fully resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showing that single-element mutations reduced but did not abolish expression established an enhanceosome-like combinatorial logic for testis-specific transcription.\",\n      \"evidence\": \"Transgenic mice with site-directed mutations in PGK2 promoter elements driving CAT\",\n      \"pmids\": [\"10330089\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Individual factor contributions not separated\", \"Did not define the order of factor assembly\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identifying PBX4/PREP1, CREM, and SP3 as enhancer-bound factors in expressing cells, with PBX4/PREP1 binding as a rate-limiting step, provided the trans-acting basis for cell-type-specific activation.\",\n      \"evidence\": \"In vivo genomic footprinting and ChIP on enriched spermatogenic cell fractions\",\n      \"pmids\": [\"17875925\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal requirement of each factor not tested by loss-of-function\", \"Single lab\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Knockout of Pgk2 showed it is the source of sperm PGK activity and is required for sperm ATP production, motility, and fertility, directly establishing PGK2's physiological function as the glycolytic enzyme replacing silenced PGK1.\",\n      \"evidence\": \"Targeted Pgk2 disruption in mice with enzymatic, ATP, motility, fertility, and histology readouts\",\n      \"pmids\": [\"19759366\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Extent of acylphosphatase compensation not quantified\", \"Did not resolve subcellular partitioning of glycolytic flux in the flagellum\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Ordering the activation program (demethylation → CAAT-factor binding → chromatin remodeling → enhancer/promoter factor binding → initiation) integrated the cis/trans findings into a sequential, stage-specific epigenetic cascade.\",\n      \"evidence\": \"ChIP for histone marks and factors, nucleosome mapping, and transgene element-disruption studies in mice\",\n      \"pmids\": [\"24000349\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal hierarchy among steps largely correlative\", \"Enzymes driving demethylation not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"A small-molecule (esculetin) was shown to bind PGK2 directly and inhibit glycolysis, raising PGK2 as a potential pharmacological target.\",\n      \"evidence\": \"Microscale thermophoresis binding and cellular glycolysis assays in HepG2 cells\",\n      \"pmids\": [\"32292350\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single binding method without mutagenesis or structural validation\", \"Cellular effects may reflect multi-target activity including GPD2 and GPI\", \"PGK2 expression in HepG2 context not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PGK2-driven ATP generation is spatially coupled to flagellar function and the extent to which alternative routes compensate for its loss remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Quantitative contribution of acylphosphatase bypass not defined\", \"No structural model distinguishing PGK2 from PGK1 function established in the corpus\", \"Loss-of-function tests of individual enhancer factors lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [10, 9]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [10, 9]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [9, 2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}